Klienditugi: 7440010 (E-R 10-18)

E-raamat: Pharmacology E-Book: A Patient-Centered Nursing Process Approach

3.90/5 (21 hinnangut Goodreads-ist)

Jennifer J. Yeager (Associat), Linda E. McCuistion (Professor (Ret.), University of Holy Cross, New Orleans, Louisiana, USA), Kathleen Vuljoin DiMaggio (Professor Emerita, University of Holy Cross, New Orleans, Louisiana, USA), Mary B. Winton (Associate Professor, Tarleton State University, Stephenville, Texas, USA)

Formaat: EPUB+DRM
Ilmumisaeg: 25-Dec-2021
Kirjastus: Saunders
Keel: eng
ISBN-13: 9780323793162

Teised raamatud teemal:

Nursing pharmacology

Formaat - EPUB+DRM
Hind: 106,59 €*
* hind on lõplik, st. muud allahindlused enam ei rakendu
Lisa ostukorvi
Lisa soovinimekirja
See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.

Formaat: EPUB+DRM
Ilmumisaeg: 25-Dec-2021
Kirjastus: Saunders
Keel: eng
ISBN-13: 9780323793162

Teised raamatud teemal:

Nursing pharmacology

DRM piirangud

Kopeerimine (copy/paste):

ei ole lubatud
Printimine:

ei ole lubatud
Kasutamine:

Digitaalõiguste kaitse (DRM)
Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

Vajalik tarkvara
Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

Seda e-raamatut ei saa lugeda Amazon Kindle's.

Gain a solid understanding of pharmacology and make it a part of patient-centered nursing care! Pharmacology: A Patient-Centered Nursing Process Approach, 11th Edition makes it easy to learn the principles of pharmacology and drug dosage calculation. A clear guide to pharmacotherapy and safe drug administration, this book uses drug prototypes to provide need-to-know information about key drugs, including dosage, side effects, interactions, and more. Nursing Process summaries enhance your skills in clinical judgment and patient care. Written by a team of nursing experts led by Linda McCuistion, this text provides the pharmacology knowledge you need to succeed on the NCLEX^? and as a professional nurse.

UNIQUE!

Prototype Drug charts

provide easy access to key information for representative drugs, including dosages, side effects, interactions, contraindications, pharmacokinetics, and more.
UNIQUE! Extensive Drug Calculations chapter features a math review as well as step-by-step instructions for frequently used methods of dosage calculation.
UNIQUE! Nursing Process summaries highlight important nursing considerations related to drug therapy and emphasize patient teaching, patient safety, and relevant cultural content.
Critical Thinking case studies challenge you to apply your knowledge and analytical skills to realistic patient scenarios, and include answer guidelines on Evolve.
Learning features include chapter outlines and objectives, review questions, and learning resources on the Evolve website.
Application-level NCLEX^? study questions include at least one alternate-style question per chapter, preparing you for the growing pharmacology coverage on the NCLEX Examination.
Safety and Quality chapter discusses medication errors, specific nursing measures to promote safety, National Patient Safety Goals, and other safety issues and concerns.
Prioritization coverage helps you learn to prioritize nursing care by listing nursing interventions in the order of priority, and a smaller font size differentiates between need-to-know and nice-to-know content.

NEW! Next Generation NCLEX^? (NGN) examination-style case studies

familiarize you to the way that content will be tested in the new NGN exam.
NEW! Updated and clinically relevant drug content includes the latest drugs and drug therapies, and removes drugs no longer being used.
NEW! Updated Nursing Process summary boxes in each chapter include the Clinical Judgment Model steps along with the nursing process.

Unit I Introduction to Pharmacology

1 Clinical Judgment Management Model (CJMM) and the Nursing Process

(7)

Explanation of Terms

(1)

Nursing Process

(1)

Patient Problems

(1)

The Nursing Alliance For Quality Care (NAQC)

(1)

Clinical Judgment [ Nursing Process]

(1)

Concept

(1)

Recognize Cues [ Assessment]

(1)

Subjective Data

(1)

Objective Data

(1)

Analyze Cues [ Analysis] and Prioritize Hypothesis [ Analysis]

(1)

Analyze Cues [ Analysis]

(1)

Prioritize Hypothesis [ Analysis]

(1)

Patient Problem(s)

(1)

Generate Solutions [ Planning]

(1)

Take Action [ Nursing Interventions]

(2)

Patient Teaching

(1)

General

(1)

Side Effects

(1)

Self-Administration

(1)

Diet

(1)

Important Nursing Considerations

(1)

Evaluate Outcomes [ Evaluation]

(2)

2 Drug Development and Ethical Considerations

(12)

Core Ethical Principles

(2)

Respect for Persons

(2)

Beneficence

(1)

Justice

(1)

Objectives and Phases of Pharmaceutical Research

(1)

Preclinical Trials

(1)

Human Clinical Experimentation

(1)

Clinical Research Study Design

(1)

American Nurses Association Code of Ethics

(1)

The Nurse's Role in Clinical Research

(1)

Drug Standards and Legislation

(4)

Drug Standards

(2)

Federal Legislation

(2)

Nurse Practice Acts

(1)

Canadian Drug Regulation

(1)

Initiatives to Combat Drug Counterfeiting

(1)

Drug Names

(1)

Over-the-Counter Drugs

(1)

Drug Resources

(4)

3 Pharmacokinetics and Pharmacodynamics

(13)

Pharmacokinetics

(4)

Drug Absorption

(2)

Drug Distribution

(1)

Drug Metabolism

(1)

Drug Excretion

(1)

Pharmacodynamics

(3)

Dose-Response Relationship

(1)

Onset, Peak, and Duration of Action

(1)

Therapeutic Drug Monitoring

(1)

Receptor Theory

(1)

Agonists, Partial Agonists, and Antagonists

(1)

Nonspecific and Nonselective Drug Effects

(1)

Mechanisms of Drug Action

(1)

Side Effects, Adverse Drug Reactions, and Drug Toxicity

(1)

Tolerance and Tachyphylaxis

(1)

Placebo Effect

(1)

Drug Interactions

(2)

Pharmacokinetic Interactions

(2)

Pharmacodynamic Interactions

(1)

Drug-Nutrient Interactions

(1)

Drug-Laboratory Interactions

(1)

Drug-Induced Photosensitivity

(4)

4 Pharmacogenetics

(5)

Brief History

(1)

Clinical Uses

(1)

Individual Variation in Metabolism of Select Drugs

(3)

Legal and Ethical Issues

(2)

5 Complementary and Alternative Therapies

(6)

Dietary Supplement Health and Education Act of 1994

(1)

Current Good Manufacturing Practices

(1)

Commonly Used Herbal Remedies

(1)

Astragalus (A. membranaceus and A. mongholicus)

(1)

Chamomile (Matricaria recutita and Chamomilla recutita)

(1)

Cinnamon (Cinnamomum zeylanicum and C. cassia)

(1)

Echinacea (Echinacea purpurea)

(1)

Garlic (Allium sativum)

(1)

Ginger (Zingiber officinale)

(1)

Ginkgo (Ginkgo biloba)

(1)

Ginseng (Panax ginseng)

(1)

Green Tea (Camellia sinensis)

(1)

Hawthorn (Crataegus laevigata and C. monogyna)

(1)

Licorice Root (Glycyrrhiza glabra and G. uralensis)

(1)

Kava Kava (Piper methysticum)

(1)

Milk Thistle (Silybum marianum)

(1)

Peppermint (Mentha piperita)

(1)

Saw Palmetto (Serenoa repens)

(1)

St. John's Wort (Hypericum perforatum)

(1)

Turmeric (Curcuma Tonga)

(1)

Valerian (Valeriana officinalis)

(1)

Potential Hazards of Herbs

(1)

Tips for Consumers and Health Care Providers

(1)

Herbal Resources

(2)

6 Pediatric Considerations

(6)

Pharmacokinetics

(1)

Absorption

(1)

Distribution

(1)

Metabolism

(1)

Excretion

(1)

Pharmacodynamics

(1)

Nursing Implications

(1)

Pediatric Drug Dosing and Monitoring

(1)

Pediatric Drug Administration

(1)

Considerations for the Adolescent Patient

(1)

Family-Centered Collaborative Care

(2)

7 Drug Therapy in Older Adults

(6)

Physiologic Changes

(1)

Pharmacokinetics

(1)

Absorption

(1)

Distribution

(1)

Metabolism

(1)

Excretion

(1)

Pharmacodynamics

(1)

Nursing Implications: Older Adult Drug Dosing and Monitoring

(1)

Polypharmacy

(1)

Beers Criteria for Potentially Inappropriate Medication Use in Older Adults

(1)

Adverse Drug Events

(1)

Adherence

(1)

Health Teaching With the Older Adult

(3)

8 Drugs in Substance Use Disorder

(16)

Substance Use Disorder

(13)

Context

(1)

Definition

(1)

Neurobiology

(1)

Types of Substance Use Disorders

(12)

Special Needs of Patients With Substance Use Disorder

(1)

Surgical Patients

(1)

Pain Management

(1)

The Nurse With Substance Use Disorder

(2)

Contributing Factors

(1)

Characteristics

(1)

Management

(2)

Unit II Pharmacotherapy and Drug Administration

9 Safety and Quality

(12)

Quality and Safety Education for Nurses

(1)

"Six Rights" of Medication Administration

(3)

Right Patient

(1)

Right Drug

(1)

Right Dose

(1)

Right Time

(1)

Right Route

(1)

Right Documentation

(1)

Just and Safe Culture

(3)

The Joint Commission National Patient Safety Goals

(1)

US Food and Drug Administration

(1)

Drug Reconciliation

(1)

Disposal of Medications

(1)

Sharps Safety

(1)

Safety Risks with Medication Administration

(2)

Counterfeit Drugs

(1)

Dosage Forms: To Crush or Not to Crush

(1)

High-Alert Medications

(1)

Look-Alike and Sound-Alike Drug Names

(1)

Other Factors in the Prevention of Medication Errors

(1)

Resources for Preventing Errors in Medication Administration

(1)

Pregnancy Categories and Subsections

(1)

Guidelines for Medication Administration

(3)

10 Drug Administration

(12)

Forms and Routes of Drug Administration

(8)

Tablets and Capsules

(1)

Liquids

(1)

Transdermals

(1)

Topical

(1)

Instillations

(1)

Inhalations

(3)

Nasogastric and Gastrostomy Tubes

(1)

Suppositories

(1)

Parenteral Medications

(4)

Nursing Implications for Administration of Parenteral Medications

(1)

Sites

(1)

Equipment

(1)

Technique

(1)

Developmental Needs of a Pediatric Patient

(3)

11 Drug Calculations

(39)

Systems of Measurement and Conversion Factors

(1)

Metric System

(1)

English System

(1)

Other Measuring Systems

(1)

Interpreting Drug Labels

(1)

Precautions When Reading Drug Labels

(2)

Drug Reconstitution

101

(1)

Calculation Methods

102

(9)

Method 1: Basic Formula

103

(1)

Method 2: Ratio and Proportion/Fractional Equation

103

(1)

Method 3: Dimensional Analysis

104

(1)

Method 4: Body Weight

105

(1)

Method 5: Body Surface Area-West Nomogram

106

(5)

Rounding Rules

111

(1)

Considerations for Enteral Administration

111

(2)

Tablets, Capsules, and Liquids

112

(1)

Drugs Administered via Nasogastric Tube

112

(1)

Considerations for Parenteral Administration

113

(7)

Injectable Preparations

113

(2)

Intravenous Routes

115

(5)

Calculating Intravenous Flow Rate: Drops Per Minute

120

(1)

Calculating Intravenous Flow Rate: Milliliters Per Hour

120

(10)

Calculating Critical Care Drugs

130

(1)

Answers to Practice Problems

130

(5)

Metric System Conversions

130

(1)

English System Conversions

131

(1)

Interpreting Drug Labels

131

(1)

Drug Reconstitution

131

(1)

Calculating Dosages Based on Body Weight

131

(1)

Calculating Dosages Based on Body Surface Area-Square Root Method

131

(1)

Enteral Administration

131

(1)

Subcutaneous and Intramuscular Administration

132

(1)

Calculating Intravenous Administration

133

(2)

Unit III Maintenance of Homeostasis

12 Fluid Volume and Electrolytes

135

(21)

Homeostasis

136

(1)

Osmolality

136

(1)

Fluid Replacement

136

(4)

General Considerations

136

(1)

Intravenous Solutions

137

(3)

Electrolytes

140

(16)

Potassium

140

(1)

Sodium

141

(3)

Calcium

144

(5)

Magnesium

149

(1)

Chloride

150

(1)

Phosphorus

150

(6)

13 Vitamin and Mineral Replacement

156

(11)

Vitamins

156

(7)

Fat-Soluble Vitamins

157

(3)

Water-Soluble Vitamins

160

(3)

Minerals

163

(4)

Iron

163

(1)

Copper

163

(1)

Zinc

163

(1)

Chromium

164

(1)

Selenium

165

(2)

14 Nutritional Support

167

(8)

Different Types of Nutritional Support

167

(8)

Oral Feeding

167

(1)

Enteral Nutrition

167

(4)

Parenteral Nutrition

171

(4)

Unit IV Autonomic Nervous System Drugs

15 Adrenergic Agonists and Antagonists

175

(12)

Sympathetic Nervous System

175

(1)

Adrenergic Agonists

175

(5)

Inactivation of Neurotransmitters

177

(1)

Classification of Sympathomimetics

177

(3)

Epinephrine

180

(1)

Central-Acting Alpha Agonists

180

(2)

Clonidine and Methyldopa

180

(2)

Adrenergic Antagonists (Adrenergic Blockers)

182

(5)

Alpha-Adrenergic Antagonists

183

(1)

Beta-Adrenergic Antagonists

183

(3)

Adrenergic Neuron Antagonists

186

(1)

16 Cholinergic Agonists and Antagonists

187

(12)

Parasympathetic Nervous System

187

(1)

Cholinergic Agonists

187

(4)

Direct-Acting Cholinergic Agonists

188

(2)

Indirect-Acting Cholinergic Agonists

190

(1)

Reversible Cholinesterase Inhibitors

190

(1)

Irreversible Cholinesterase Inhibitors

191

(1)

Cholinergic Antagonists

191

(8)

Atropine

191

(3)

Antiparkinson Anticholinergic Drugs

194

(1)

Anticholinergics for Treating Motion Sickness

194

(5)

Unit V Central and Peripheral Nervous System Drugs

17 Stimulants

199

(7)

Pathophysiology

199

(1)

Amphetamines

200

(1)

Side Effects and Adverse Reactions

200

(1)

Amphetamine-Like Drugs for Attention-Deficit/Hyperactivity Disorder and Narcolepsy

200

(1)

Anorexiants and Analeptics

200

(6)

Anorexiants

200

(1)

Analeptics

201

(5)

18 Depressants

206

(13)

Types and Stages of Sleep

206

(1)

Nonpharmacologic Methods

206

(1)

Sedative-Hypnotics

207

(6)

Barbiturates

208

(1)

Benzodiazepines

208

(3)

Nonbenzodiazepines

211

(1)

Melatonin Agonists

211

(1)

Sedatives and Hypnotics for Older Adults

211

(2)

Anesthetics

213

(6)

Pathophysiology

213

(1)

Balanced Anesthesia

213

(1)

Stages of General Anesthesia

213

(1)

Assessment Before Surgery

213

(1)

Inhalation Anesthetics

214

(1)

Intravenous Anesthetics

214

(1)

Topical Anesthetics

215

(1)

Local Anesthetics

215

(1)

Spinal Anesthesia

215

(4)

19 Antiseizure Drugs

219

(9)

International Classification of Seizures

219

(1)

Antiseizure Drugs

219

(9)

Pharmacophysiology: Action of Antiseizure Drugs

219

(1)

Hydantoins

220

(2)

Barbiturates

222

(1)

Succinimides

222

(1)

Benzodiazepines

222

(1)

Iminostilbenes

222

(1)

Valproic Acid

222

(1)

Antiseizure Drugs and Pregnancy

222

(1)

Antiseizure Drugs and Febrile Seizures

222

(1)

Antiseizure Drugs and Status Epilepticus

222

(6)

20 Drugs for Parkinsonism and Alzheimer Disease

228

(13)

Parkinson Disease

228

(9)

Parkinsonism and Extrapyramidal Symptoms

229

(1)

Nonpharmacologic Measures

229

(1)

Pathophysiology

229

(1)

Anticholinergics

229

(2)

Dopaminergics

231

(1)

Dopamine Agonists

232

(1)

Monoamine Oxidase B Inhibitors

232

(1)

Catechol-O-Methyltransferase Inhibitors

232

(1)

Dopamine Receptor Antagonists

232

(4)

Precautions for Drugs Used to Treat Parkinson Disease

236

(1)

Alzheimer Disease

237

(4)

Pathophysiology

237

(1)

Acetylcholinesterase/Cholinesterase Inhibitors

237

(1)

lgG1 Monoclonal Antibody

238

(3)

21 Drugs for Neuromuscular Disorders and Muscle Spasms

241

(13)

Myasthenia Gravis

241

(3)

Pathophysiology

241

(1)

Acetylcholinesterase Inhibitors

242

(2)

Multiple Sclerosis

244

(4)

Classifications of Multiple Sclerosis

244

(1)

Immunomodulators

245

(3)

Skeletal Muscle Relaxants

248

(6)

Centrally Acting Muscle Relaxants

248

(6)

Unit VI Mental and Behavioral Health Drugs

22 Antipsychotics and Anxiolytics

254

(14)

Introduction

254

(1)

Psychosis

255

(1)

Antipsychotic Agents

255

(7)

Pharmacophysiologic Mechanisms of Action

255

(1)

Adverse Reactions

255

(1)

Phenothiazines

256

(2)

Nonphenothiazines

258

(1)

Antipsychotic Dosage for Older Adults

259

(1)

Atypical Antipsychotics (Serotonin/Dopamine Antagonists)

259

(3)

Anxiolytics

262

(6)

Nonpharmacologic Measures

262

(1)

Benzodiazepines

262

(2)

Miscellaneous Anxiolytics

264

(4)

23 Antidepressants and Mood Stabilizers

268

(11)

Depression

268

(1)

Pathophysiology

268

(1)

Complementary and Alternative Therapy for Depression

269

(1)

Antidepressant Agents

269

(2)

Tricyclic Antidepressants

269

(1)

Selective Serotonin Reuptake Inhibitors

269

(2)

Serotonin Norepinephrine Reuptake Inhibitors

271

(1)

Atypical Antidepressants

271

(1)

Monoamine Oxidase Inhibitors

271

(1)

Mood Stabilizers

271

(8)

Unit VII Pain and Inflammation Management Drugs

24 Antiinflammatories

279

(16)

Introduction

279

(1)

Pathophysiology

279

(1)

Antiinflammatory Agents

280

(1)

Nonsteroidal Antiinflammatory Drugs

281

(6)

Salicylates

283

(1)

Para-Chlorobenzoic Acid

284

(1)

Propionic Acid Derivatives

285

(1)

Fenamates

285

(1)

Oxicams

286

(1)

Selective COX-2 Inhibitors

286

(1)

Use of NSAIDs in Older Adults

287

(1)

Corticosteroids

287

(1)

Disease-Modifying Antirheumatic Drugs

287

(4)

Immunosuppressive Agents

288

(1)

Immunomodulators

288

(3)

Antimalarials

291

(1)

Antigout Drugs

291

(4)

Antiinflammatory Gout Drug: Colchicine

291

(1)

Xanthine Oxidase Inhibitors

291

(1)

Uricosurics

292

(3)

25 Analgesics

295

(17)

Pathophysiology

296

(1)

Undertreatment of Pain

296

(1)

Nonopioid Analgesics

296

(2)

Nonsteroidal Antiinflammatory Drugs

297

(1)

Acetaminophen

297

(1)

Opioid Analgesics

298

(7)

Morphine

301

(1)

Meperidine

302

(2)

Hydromorphone

304

(1)

Combination Drugs

304

(1)

Patient-Controlled Analgesia

304

(1)

Transdermal Opioid Analgesics

304

(1)

Analgesic Titration

304

(1)

Opioid Use in Special Populations

304

(1)

Adjuvant Therapy

305

(1)

Treatment for Substance Use Disorder

306

(1)

Opioid Agonist-Antagonists

306

(1)

Opioid Antagonists

306

(1)

Headaches: Migraine and Cluster

306

(6)

Pathophysiology

308

(1)

Treatment of Migraine Headaches

308

(4)

Unit VIII Antimicrobial Drugs

26 Penicillins, Other Beta-Lactams, and Cephalosporins

312

(12)

Introduction

312

(1)

Pathophysiology

312

(1)

Antibacterial Drugs

313

(2)

Antibacterials/Antibiotics

313

(2)

Mechanisms of Antibacterial Action

313

(1)

Body Defenses

314

(1)

Resistance to Antibacterials

314

(1)

Use of Antibiotic Combinations

315

(1)

General Adverse Reactions to Antibacterials

315

(1)

Narrow-Spectrum and Broad-Spectrum Antibiotics

315

(1)

Penicillins and Cephalosporins

315

(9)

Penicillins

315

(4)

Broad-Spectrum Penicillins (Aminopenicillins)

316

(1)

Penicillinase-Resistant Penicillins (Antistaphylococcal Penicillins)

316

(1)

Extended-Spectrum Penicillins (Antipseudomonal Penicillins)

316

(1)

Beta-Lactamase Inhibitors

316

(2)

Geriatrics

318

(1)

Side Effects and Adverse Reactions

318

(1)

Drug Interactions

318

(1)

Other Beta-Lactam Antibacterials

319

(1)

Side Effects and Adverse Reactions

319

(1)

Cephalosporins

319

(5)

First-, Second-, Third-, Fourth-, and Fifth-Generation Cephalosporins

319

(3)

Side Effects and Adverse Reactions

322

(1)

Drug Interactions

323

(1)

27 Macrolides, Oxazolidinones, Lincosamides, Glycopeptides, Ketolides, and Lipopeptides

324

(6)

Introduction

324

(1)

Macrolides

324

(3)

Side Effects and Adverse Reactions

326

(1)

Drug Interactions

326

(1)

Extended Macrolide Group

326

(1)

Oxazolidinones

327

(1)

Side Effects and Adverse Reactions

327

(1)

Lincosamides

327

(1)

Side Effects and Adverse Reactions

327

(1)

Drug Interactions

327

(1)

Glycopeptides

328

(1)

Side Effects and Adverse Reactions

328

(1)

Drug Interactions

328

(1)

Ketolides

328

(1)

Side Effects and Adverse Reactions

328

(1)

Drug Interactions

328

(1)

Lipopeptides

328

(2)

Side Effects and Adverse Reactions

328

(1)

Drug Interactions

329

(1)

28 Tetracyclines, Glycylcyclines, Aminoglycosides, and Fluoroquinolones

330

(9)

Introduction

330

(1)

Tetracyclines

330

(1)

Side Effects and Adverse Reactions

331

(1)

Drug Interactions

331

(1)

Glycylcyclines

331

(3)

Side Effects and Adverse Reactions

334

(1)

Drug Interactions

334

(1)

Aminoglycosides

334

(3)

Side Effects and Adverse Reactions

336

(1)

Drug Interactions

336

(1)

Fluoroquinolones (Quinolones)

337

(2)

29 Sulfonamides and Nitroimidazoles Antibiotics

339

(6)

Introduction

339

(1)

Sulfonamides

339

(2)

Side Effects and Adverse Reactions

340

(1)

Trimethoprim-Sulfamethoxazole

340

(1)

Topical and Ophthalmic Sulfonamides

340

(1)

Nitroimidazoles

341

(2)

Side Effects and Adverse Reactions

343

(1)

Miscellaneous Antibacterial Drugs

343

(2)

30 Antituberculars, Antifungals, and Antivirals

345

(15)

Tuberculosis

345

(3)

Pathophysiology

345

(1)

Antitubercular Drugs

346

(1)

Side Effects and Adverse Reactions

346

(1)

Special Populations

346

(2)

Tuberculosis and Pregnancy

346

(1)

Tuberculosis and HIV Coinfection

346

(2)

Tuberculosis and Pediatrics

348

(1)

Tuberculosis and Other Special Populations

348

(1)

Fungus

348

(4)

Pathophysiology

348

(2)

Antifungal Drugs

350

(2)

Polyenes

350

(1)

Azole Antifungals

350

(1)

Antimetabolites

350

(1)

Echinocandins

350

(2)

Viruses

352

(8)

Pathophysiology

352

(2)

Non-HIV Antivirals

354

(6)

Influenza Antivirals

354

(1)

Herpes Antivirals

354

(3)

Cytomegalovirus Antivirals

357

(1)

Hepatitis Antivirals

358

(2)

31 Antimalarials, Anthelmintics, and Peptides

360

(11)

Antimalarial Drugs

360

(3)

Side Effects and Adverse Reactions

361

(2)

Anthelmintic Drugs

363

(1)

Side Effects and Adverse Reactions

364

(1)

Peptides

364

(7)

Colistimethate

365

(1)

Polymyxins

366

(1)

Bacitracin

367

(1)

Metronidazole

367

(4)

Unit IX Immunologic Drugs

32 HIV- and AIDS-Related Drugs

371

(15)

HIV Infection: Pathophysiology

372

(1)

HIV Transmission

372

(1)

Laboratory Testing

372

(1)

Classification

372

(1)

Indications for Antiretroviral Therapy

372

(1)

Antiretroviral Drugs

373

(9)

Nucleoside/Nucleotide Reverse Transcriptase Inhibitors

373

(1)

Nonnucleoside Reverse Transcriptase Inhibitors

373

(5)

Protease Inhibitors

378

(2)

Fusion (Entry) Inhibitors

380

(1)

Chemokine (CCR5) Coreceptor Antagonists

380

(1)

Integrase Strand Transfer Inhibitors

381

(1)

Immune Reconstitution Inflammatory Syndrome

382

(1)

The Nurse's Role in Antiretroviral Therapy

382

(1)

Opportunistic Infections

382

(2)

Antiretroviral Therapy in Pregnancy

384

(1)

Occupational HIV Exposure and Postexposure Prophylaxis

384

(2)

33 Transplant Drugs

386

(12)

Organ Transplantation

386

(8)

Principles of Immunosuppression

386

(1)

Immunosuppressant Drugs

386

(6)

Drugs for Transplant Rejection

392

(2)

Drugs for Infection

394

(1)

Promoting Adherence

394

(4)

34 Vaccines

398

(11)

Immunity

398

(1)

Active Immunity

398

(1)

Passive Immunity

399

(1)

Community Immunity

399

(1)

Vaccines

399

(1)

Vaccine-Preventable Diseases

400

(1)

Vaccination Recommendations

400

(4)

Immunization Before International Travel

404

(1)

Vaccine Safety: Reporting Diseases and Adverse Reactions

404

(1)

Varicella Vaccine

405

(1)

Contraindications

405

(1)

Drug Interactions

406

(1)

Future Developments in Vaccines

406

(3)

Unit X Antineoplastics and Biologic Response Modifiers

35 Anticancer Drugs

409

(25)

Genetic, Inflammatory, Infective, Environmental, and Dietary Influences

410

(1)

Cell Cycle-Nonspecific and Cell Cycle-Specific Anticancer Drugs

411

(1)

Cancer Chemotherapy

412

(1)

Combination Chemotherapy

413

(1)

General Side Effects and Adverse Reactions

413

(1)

Anticancer Therapy in Outpatient Settings

413

(1)

Alkylating Drugs

413

(4)

Cyclophosphamide

415

(2)

Antimetabolites

417

(4)

Fluorouracil

417

(4)

Antitumor Antibiotics

421

(2)

Anthracyclines: Doxorubicin

421

(2)

Plant Alkaloids

423

(5)

Vincristine

425

(3)

Immunomodulators

428

(1)

Targeted Therapies

429

(1)

Liposomal Chemotherapy

429

(1)

Hormones and Hormonal Agonists and Antagonists

429

(1)

Corticosteroids

430

(1)

Sex Hormones

430

(1)

Antiandrogens

430

(1)

Selective Estrogen Receptor Modulators

430

(1)

Luteinizing Hormone-Releasing Hormone Agonists

430

(1)

Aromatase Inhibitors

430

(1)

Biologic Response Modifiers

430

(1)

Miscellaneous Chemotherapy Agents

430

(1)

Vaccines

430

(4)

36 Targeted Therapies to Treat Cancer

434

(19)

Targeted Therapy Drugs

434

(19)

Small-Molecule Compounds

435

(11)

Large-Molecule Compounds

446

(7)

37 Biologic Response Modifiers

453

(10)

Interferons

453

(3)

Interferon Alfa

454

(2)

Interferon Beta

456

(1)

Interferon Gamma

456

(1)

Colony-Stimulating Factors

456

(3)

Erythropoietin-Stimulating Agents

456

(2)

Granulocyte Colony-Stimulating Factor

458

(1)

Granulocyte-Macrophage Colony-Stimulating Factor

458

(1)

Interleukin 2

459

(4)

Unit XI Respiratory Drugs

38 Upper Respiratory Disorders

463

(9)

Introduction

463

(1)

Common Cold, Acute Rhinitis, and Allergic Rhinitis

463

(6)

Antihistamines

464

(1)

Nasal and Systemic Decongestants

465

(2)

Intranasal Glucocorticoids

467

(1)

Antitussives

468

(1)

Expectorants

469

(1)

Sinusitis

469

(1)

Acute Pharyngitis

469

(3)

39 Lower Respiratory Disorders

472

(14)

Introduction

472

(1)

Lung Compliance

472

(1)

Control of Respiration

472

(1)

Bronchial Smooth Muscle

473

(1)

Chronic Obstructive Pulmonary Disease

473

(2)

Bronchial Asthma

474

(1)

Sympathomimetics: Alpha- and Beta2-Adrenergic Agonists

475

(1)

Albuterol

475

(1)

Metaproterenol

476

(1)

Use of an Aerosol Inhaler

476

(1)

Side Effects and Adverse Reactions

476

(1)

Anticholinergics

476

(2)

Methylxanthine (Xanthine) Derivatives

478

(1)

Aminophylline-Theophylline

479

(1)

Leukotriene Receptor Antagonists and Synthesis Inhibitors

479

(2)

Glucocorticoids (Steroids)

481

(3)

Cromolyn

484

(1)

Drug Therapy for Asthma According to Severity

484

(1)

Drug Therapy for Asthma According to Age

484

(1)

Young Children

484

(1)

Older Adults

484

(1)

Antimicrobials

484

(2)

Unit XII Cardiovascular Drugs

40 Cardiac Glycosides, Antianginals, and Antidysrhythmics

486

(21)

Introduction

486

(1)

Heart

486

(1)

Conduction of Electrical Impulses

487

(1)

Regulation of Heart Rate and Blood Flow

487

(1)

Circulation

487

(1)

Blood

488

(1)

Laboratory Tests to Diagnose Heart Failure

488

(1)

Atrial Natriuretic Hormone or Peptide

488

(1)

Brain Natriuretic Peptide

488

(1)

Nonpharmacologic Measures to Treat Heart Failure

488

(1)

Agents Used To Treat Heart Failure

488

(4)

Cardiac Glycosides

488

(1)

Digoxin

489

(2)

Phosphodiesterase Inhibitors

491

(1)

Other Agents Used to Treat Heart Failure

491

(1)

Antianginal Drugs

492

(5)

Types of Angina Pectoris

492

(1)

Nonpharmacologic Measures to Control Angina

492

(1)

Types of Antianginal Drugs

492

(5)

Antidysrhythmic Drugs

497

(10)

Cardiac Dysrhythmias

497

(1)

Cardiac Action Potentials

497

(1)

Types of Antidysrhythmic Drugs

498

(9)

41 Diuretics

507

(11)

Thiazides and Thiazide-Like Diuretics

507

(3)

Loop Diuretics

510

(2)

Osmotic Diuretics

512

(2)

Carbonic Anhydrase Inhibitors

514

(1)

Potassium-Sparing Diuretics

514

(4)

42 Antihypertensives

518

(15)

Hypertension

518

(1)

Guidelines for Hypertension

518

(1)

Selected Regulators of Blood Pressure

518

(1)

Physiologic Risk Factors

519

(1)

Cultural Responses to Antihypertensive Agents

519

(1)

Hypertension in Older Adults

519

(1)

Nonpharmacologic Control of Hypertension

519

(1)

Pharmacologic Control of Hypertension

519

(14)

Diuretics

520

(1)

Sympatholytics (Sympathetic Depressants)

520

(6)

Direct-Acting Arteriolar Vasodilators

526

(1)

Angiotensin-Converting Enzyme Inhibitors

526

(1)

Angiotensin II-Receptor Blockers

527

(3)

Direct Renin Inhibitors

530

(1)

Calcium Channel Blockers

530

(3)

43 Anticoagulants, Antiplatelets, and Thrombolytics

533

(11)

Pathophysiology: Thrombus Formation

533

(1)

Anticoagulants

533

(6)

Heparin

533

(1)

Direct Thrombin Inhibitors: Parenteral Anticoagulants II

534

(1)

Oral Anticoagulants

534

(3)

Factor Xa Inhibitors

537

(1)

Anticoagulant Antagonists

538

(1)

Antiplatelet Drugs

539

(2)

Thrombolytics

541

(3)

44 Antihyperlipidemics and Drugs to Improve Peripheral Blood Flow

544

(9)

Lipoproteins

544

(1)

Apolipoproteins

544

(1)

Nonpharmacologic Methods of Cholesterol Reduction

544

(1)

Antihyperlipidemics

545

(1)

Statins

545

(1)

Drugs to Improve Peripheral Blood Flow

546

(7)

Cilostazol

548

(1)

Pentoxifylline

548

(5)

Unit XIII Gastrointestinal Drugs

45 Gastrointestinal Tract Disorders

553

(16)

Overview of the Gastrointestinal System

553

(1)

Oral Cavity

553

(1)

Esophagus

553

(1)

Stomach

554

(1)

Small Intestine

554

(1)

Large Intestine

554

(1)

Drugs for Gastrointestinal Disorders

554

(15)

Vomiting

554

(6)

Nonpharmacologic Measures

555

(1)

Nonprescription Antiemetics

555

(1)

Prescription Antiemetics

556

(4)

Emetics

560

(1)

Diarrhea

560

(2)

Nonpharmacologic Measures

560

(1)

Travelers' Diarrhea

560

(1)

Antidiarrheals

560

(2)

Constipation

562

(7)

Nonpharmacologic Measures

562

(1)

Laxatives

563

(6)

46 Antiulcer Drugs

569

(12)

Predisposing Factors in Peptic Ulcer Disease

569

(2)

Helicobacter pylori

570

(1)

Gastroesophageal Reflux Disease

570

(1)

Nonpharmacologic Measures for Managing Peptic Ulcer and Gastroesophageal Reflux Disease

571

(1)

Antiulcer Drugs

571

(10)

Tranquilizers

572

(1)

Anticholinergics

572

(1)

Antacids

572

(2)

Histamine

Blockers

574

(2)

Proton Pump Inhibitors (Gastric Acid Secretion Inhibitors, Gastric Acid Pump Inhibitors)

576

(2)

Pepsin Inhibitors (Mucosal Protective Drugs)

578

(2)

Prostaglandin Analogue Antiulcer Drug

580

(1)

Unit XIV Eye, Ear, and Skin Drugs

47 Eye and Ear Disorders

581

(16)

Overview of the Eye

581

(1)

Drugs for Disorders of the Eye

581

(11)

Diagnostic Stains

582

(1)

Topical Anesthetics

582

(1)

Antiinfectives

582

(1)

Antiinflammatories

582

(3)

Decongestants

585

(1)

Lubricants

585

(1)

Glaucoma and Ocular Hypertension Drugs

585

(4)

Mydriatics and Cycloplegics

589

(1)

Drugs for Macular Degeneration

590

(1)

Drugs for Inherited Retinal Dystrophies

591

(1)

Administration of Eyedrops and Ointments

591

(1)

Patients With Eye Disorders: General Suggestions for Teaching

591

(1)

Overview of the Ear

592

(1)

Drugs for Disorders of the Ear

592

(5)

Antiinfectives

592

(1)

Antihistamines and Decongestants

593

(1)

Cerumenolytics

594

(1)

Administration of Ear Medications

594

(1)

Patients With Ear Disorders: General Suggestions for Teaching

594

(3)

48 Dermatologic Disorders

597

(12)

Overview of the Skin

597

(1)

Acne Vulgaris

597

(4)

Nonpharmacologic Approach

598

(1)

Pharmacologic Treatment

598

(3)

Psoriasis

601

(3)

Topical Drugs

602

(1)

Systemic Drugs

603

(1)

Verruca Vulgaris (Warts)

604

(1)

Drug-Induced Dermatitis

604

(1)

Contact Dermatitis

605

(1)

Impetigo

605

(1)

Rosacea

605

(1)

Hair Loss and Baldness

605

(1)

Sunscreens

605

(1)

Burns and Burn Preparations

606

(3)

Silver Sulfadiazine

606

(3)

Unit XV Endocrine Drugs

49 Pituitary, Thyroid, Parathyroid, and Adrenal Disorders

609

(16)

Pituitary Gland

609

(5)

Anterior Lobe

609

(4)

Posterior Lobe

613

(1)

Thyroid Gland

614

(4)

Hypothyroidism

614

(2)

Hyperthyroidism

616

(2)

Parathyroid Glands

618

(2)

Hypoparathyroidism

618

(1)

Hyperparathyroidism

618

(2)

Adrenal Glands

620

(5)

Glucocorticoids

620

(1)

Mineralocorticoids

620

(5)

50 Antidiabetics

625

(14)

Introduction

625

(1)

Diabetes Mellitus

625

(14)

Insulin

626

(4)

Oral Antidiabetic (Hypoglycemic) Drugs

630

(6)

Other Antidiabetic Agents

636

(1)

Hyperglycemic Drugs

636

(3)

Unit XVI Renal and Urologic Drugs

51 Urinary Disorders

639

(8)

Introduction

639

(1)

Urinary Antiseptics/Antiinfectives and Antibiotics

640

(3)

Trimethoprim and Trimethoprim- Sulfamethoxazole

640

(1)

Methenamine

641

(1)

Nitrofurantoin

641

(1)

Fluoroquinolones (Quinolones)

642

(1)

Side Effects and Adverse Reactions

642

(1)

Drug-Drug Interactions

643

(1)

Urinary Analgesics

643

(1)

Phenazopyridine

643

(1)

Urinary Stimulants

643

(1)

Urinary Antispasmodics/Antimuscarinics/Anticholinergics

644

(3)

Unit XVII Reproductive and Gender-Related Drugs

52 Pregnancy and Preterm Labor

647

(16)

Physiology of Pregnancy

647

(1)

Therapeutic Drugs and Use of Herbs in Pregnancy

648

(6)

Iron

648

(1)

Folic Acid

649

(1)

Multiple Vitamins

649

(1)

Drugs for Minor Discomforts of Pregnancy

649

(4)

Antidepressant Drugs

653

(1)

Drugs That Decrease Uterine Muscle Contractility

654

(3)

Preterm Labor

654

(1)

Tocolytic Therapy

655

(2)

Corticosteroid Therapy in Preterm Labor

657

(1)

Betamethasone

657

(1)

Dexamethasone

657

(1)

Drugs for Gestational Hypertension

657

(6)

Drugs Used to Treat Preeclampsia

658

(5)

53 Labor, Delivery, and Postpartum

663

(19)

Drugs For Pain Control During Labor

663

(7)

Analgesia and Sedation

664

(3)

Anesthesia: Local, Regional, and General

667

(3)

Drugs That Enhance Uterine Muscle Contractility

670

(4)

Oxytocin

672

(1)

Other Drugs That Enhance Uterine Contractions: Ergot Alkaloids

673

(1)

Drugs Used During the Postpartum Period

674

(5)

Pain Relief for Uterine Contractions

675

(1)

Pain Relief for Perineal Wounds and Hemorrhoids

676

(1)

Lactation Suppression

677

(1)

Promotion of Bowel Function

678

(1)

Immunizations

679

(1)

Rho(D) Immune Globulin

679

(1)

Rubella Vaccine

680

(1)

Postpartum Depression

680

(2)

54 Neonatal and Newborn

682

(5)

Drugs Administered to Preterm Neonates

682

(1)

Synthetic Surfactant

682

(1)

Drugs Administered to Full-Term, Healthy Neonates

683

(4)

Erythromycin Ophthalmic Ointment

683

(1)

Phytonadione

683

(1)

Immunizations

683

(4)

55 Women's Reproductive Health

687

(26)

Drugs Used for Contraception

687

(9)

Combined Hormonal Contraceptives

687

(4)

Progestin Contraceptives

691

(1)

Start Date and Dosing Schedule for Starting Hormonal Contraception Products

692

(1)

Contraindications

692

(1)

Drug Interactions

692

(1)

Potential Side Effects and Adverse Reactions

692

(4)

Preventing Fertilization

696

(1)

Drugs Used to Treat Disorders in Women's Health

696

(3)

Irregular or Abnormal Uterine Bleeding

696

(1)

Dysmenorrhea

697

(1)

Endometriosis

698

(1)

Premenstrual Syndrome

699

(1)

Drugs Used to Promote Fertility

699

(4)

Assessing the Infertile Couple

699

(1)

Induction of Ovulation

700

(3)

Other Drug Treatments

703

(1)

Menopause

703

(10)

Perimenopause

703

(1)

Menopause

703

(1)

Postmenopause

703

(1)

Pharmacologic Therapy for Perimenopausal and Menopausal Symptoms

704

(2)

Osteoporosis

706

(7)

56 Men's Reproductive Health

713

(9)

Drugs Related to Male Reproductive Disorders

713

(9)

Androgens

713

(3)

Anabolic Steroids

716

(1)

Antiandrogens

716

(2)

Drugs Used in Other Male Reproductive Disorders

718

(4)

57 Sexually Transmitted Infections

722

(9)

Sexually Transmitted Infections

722

(1)

Sexually Transmitted Pathogens

723

(4)

Bacterial Pathogens

723

(3)

Viral Pathogens

726

(1)

Other Pathogens

727

(1)

Prevention of Sexually Transmitted Infections

727

(4)

Unit XVIII Adult and Pediatric Emergency Drugs

58 Adult and Pediatric Emergency Drugs

731

(16)

Introduction

731

(1)

Oxygen as an Emergency Drug

732

(1)

Emergency Drugs For Cardiac Disorders

732

(4)

Aspirin

732

(1)

Nitroglycerin

732

(1)

Morphine Sulfate

733

(1)

Atropine Sulfate

733

(1)

Adenosine

733

(1)

Diltiazem

734

(1)

Amiodarone

734

(1)

Lidocaine

734

(1)

Procainamide

735

(1)

Magnesium Sulfate

735

(1)

Epinephrine

735

(1)

Sodium Bicarbonate

736

(1)

Emergency Drug For Intracranial Hypertension

736

(1)

Mannitol

736

(1)

Emergency Drugs For Drug Overdose

736

(3)

Naloxone

736

(2)

Flumazenil

738

(1)

Activated Charcoal

738

(1)

Emergency Drugs For Shock

739

(3)

Dopamine

740

(1)

Dobutamine

740

(1)

Norepinephrine

740

(1)

Epinephrine

741

(1)

Albuterol

741

(1)

Diphenhydramine Hydrochloride

741

(1)

Dextrose 50%

741

(1)

Glucagon

742

(1)

Emergency Drugs for Hypertensive Crises

742

(5)

Labetalol

742

(1)

Nitroprusside Sodium

743

(1)

Furosemide

744

(3)

Appendix A: Answers to Review Questions

747

(2)

Appendix B: Solution Compatibility Chart

749

(2)

Appendix C: Immunizations

751

(3)

Bibliography

754

(3)

Glossary

757

(11)

Index

768

Professor (Ret.), University of Holy Cross, New Orleans, Louisiana Professor Emerita Kathleen Vuljoin DiMaggio works at the University of Holy Cross in New Orleans, Louisiana. Associate Professor Mary B. Winton works at Tarleton State University, Stephenville, Texas. Associate Professor Jennifer J. Yeager works at Tarleton State University, Stephenville, Texas.

Lisainfo e-raamatute kohta

Püsilink: https://www.kriso.ee/db/97803237931626e.html

Märksõnad:

E-raamat: Pharmacology E-Book: A Patient-Centered Nursing Process Approach

DRM piirangud

Kopeerimine (copy/paste):

Printimine:

Kasutamine:

Konto & seaded

Otsing

Otsingu andmebaas

Filtreeri tulemusi

Teemad E-raamatute teemad

Vali ostukorv